Thuja Capital

Bringing innovations to patients

General information

HQ

Utrecht, Utrecht

Description

Thuja Capital Management (“Thuja Capital”) is an independent venture capital management firm specialized in investing in early-stage medical product companies in the Netherlands and Belgium.

The team of Thuja Capital has a long-standing and successful track record in investments in, and management of, medical product companies.

Thuja Capital takes a unique position: it is the only independent medical product VC with an investment focus on the Benelux. Moreover, we are among the declining number of VCs that invest at a truly early stage.

In addition to capital investments we leverage our extensive network, advisory board and our own experience to help and turn good science into valuable innovative medical products. We believe that we should work closely with our portfolio companies and provide hands-on support. By taking an active role, Thuja Capital aims to help these companies to strengthen and grow their businesses. 

Founder

Harrold van Barlingen (Founder & Managing Partner)

Team

Michel Briejer (Managing Partner), Florian Ludwig (Life Science investor and company scout), Martin Solleveld (Financial Controller)

Socials

Contact information

Investment information

Investment type

Seed investments, early stage venture investments

Investment size

200k – 2.5M

Investing in

Health Care, Biotechnology, Medical Technology, Medical Devices, Diagnostics, Medical Food, Pharmaceuticals

Focus regions

Netherlands, Belgium and Luxembourg

Investments made

Indigo Diabetes, Nightbalance, FABPulous, Hemics, Cristal Therapeutics, arGEN-X

Exits

arGEN-X (IPO)